tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
2M ago
Rallybio Sells REV102 Program to Recursion Pharmaceuticals
Premium
Company Announcements
Rallybio Sells REV102 Program to Recursion Pharmaceuticals
2M ago
Rallybio to sell interest in REV102 to Recursion Pharmaceuticals for up to $25M
Premium
The Fly
Rallybio to sell interest in REV102 to Recursion Pharmaceuticals for up to $25M
2M ago
Rallybio initiates dosing in RLYB116 study
PremiumThe FlyRallybio initiates dosing in RLYB116 study
3M ago
Rallybio Elects New Directors at Shareholder Meeting
Premium
Company Announcements
Rallybio Elects New Directors at Shareholder Meeting
4M ago
Rallybio Reports Q1 2025 Financial Results and Strategic Updates
Premium
Company Announcements
Rallybio Reports Q1 2025 Financial Results and Strategic Updates
4M ago
Citizens JMP downgrades Rallybio on RLYB212 discontinuation
PremiumThe FlyCitizens JMP downgrades Rallybio on RLYB212 discontinuation
5M ago
Rallybio downgraded to Market Perform from Outperform at Citizens JMP
Premium
The Fly
Rallybio downgraded to Market Perform from Outperform at Citizens JMP
5M ago
Rallybio discontinues RLYB212 program
Premium
The Fly
Rallybio discontinues RLYB212 program
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100